{"id":"CHEMBL1078178","canonicalSmiles":"N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1","inchiKey":"ZVHNDZWQTBEVRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOMELOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYT-0387","CYT-11387","CYT-387","CYT387","Cyt-387","GS-0387","Momelotinib"],"crossReferences":{"PubChem":["137275866"],"drugbank":["DB11763"]},"childChemblIds":["CHEMBL2219411"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434"],"count":2},"linkedDiseases":{"rows":["EFO_0002430","MONDO_0044903","EFO_0002517","EFO_0002429","EFO_0003060","EFO_0000479"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1086","canonicalSmiles":"CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1","inchiKey":"PUFQVTATUTYEAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBUCAINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nupercainal"],"synonyms":["Cinchocaine","Dibucaine","NSC-159055"],"crossReferences":{"PubChem":["11112228","144203932","170464829","50100394","50100395","56424123","855529"],"Wikipedia":["Cinchocaine"],"drugbank":["DB00527"],"chEBI":["247956"]},"childChemblIds":["CHEMBL1200612"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000183873"],"count":2},"linkedDiseases":{"rows":["HP_0000989","EFO_0003958","EFO_0009552"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 approved indications."}
{"id":"CHEMBL109162","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)O)cc1N","inchiKey":"MJMLUICFHWSBQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109162","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02268"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1185242","canonicalSmiles":"CS(=O)(=O)c1ccc(-c2noc([C@@H](CC3CC3)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1","inchiKey":"XCCSSVMRGIQMGF-LPHOPBHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1185242","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06994"]},"childChemblIds":["CHEMBL402163"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200396","canonicalSmiles":"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl","inchiKey":"SIEYLFHKZGLBNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPIVACAINE HYDROCHLORIDE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1098","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bupivac hcl","Bupivacaine hydrochloride","Bupivacaine hydrochloride kit","Bupivacaine hydrochloride preservative free","Marcain","Marcaine","Marcaine hydrochloride","Marcaine hydrochloride preservative free","Sensorcaine","Xaracoll"],"synonyms":["AH-2250","Bupivacaine hcl","Bupivacaine hydrochloride","Bupivacaine hydrochloride hydrate","Bupivacaine hydrochloride monohydrate","Bupivacaine hydrochloride rs","Bupivacaini hydrochloridum","Carbostesin","LAC-43","NSC-758631","WIN 11,318","WIN-11318","Xaracoll"],"crossReferences":{"DailyMed":["bupivacaine%20hydrochloride"],"PubChem":["26748842","56463371"],"chEBI":["31322"]},"linkedTargets":{"rows":["ENSG00000007314"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0004880","EFO_0011061","HP_0012532","HP_0030838","MONDO_0002959","MONDO_0007254","HP_0000175","EFO_0000284","HP_0031217","MONDO_0002087","EFO_0003843","HP_0030016","EFO_0000311","EFO_0003964","EFO_0000546","MONDO_0005277","EFO_0003931","HP_0003040","HP_0030834","EFO_0000764","EFO_0009552","EFO_0005611","HP_0001822","MONDO_0005178","HP_0000023"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for pain and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200448","canonicalSmiles":"O=P([O-])(O)C(Sc1ccc(Cl)cc1)P(=O)([O-])O.[Na+].[Na+]","inchiKey":"SKUHWSDHMJMHIW-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"TILUDRONATE DISODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1350","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Skelid"],"synonyms":["SR 41319B","SR-41319B","Tiludronate disodium","Tiludronate disodium anhydrous","Tiludronate sodium","Tiludronic acid disodium salt"],"crossReferences":{"PubChem":["144206514"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL1200597","canonicalSmiles":"CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C.Cl","inchiKey":"LMWQQUMMGGIGJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIDOCAINE HYDROCHLORIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL492","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duranest"],"synonyms":["Duranest hydrochloride","Etidocaine hcl","Etidocaine hydrochloride","W-19053"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL1200624","canonicalSmiles":"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"ONKUMRGIYFNPJW-KIEAKMPYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYNODIOL DIACETATE","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Femulen"],"synonyms":["Ethynodiol diacetate","Etynodiol","Etynodiol acetate","Etynodiol diacetate","NSC-759288","SC 11800","SC-11800"],"crossReferences":{"DailyMed":["ethynodiol%20diacetate"],"PubChem":["144205886","144206477","170464933","29217896"],"drugbank":["DB00823"],"chEBI":["31580"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1966."}
{"id":"CHEMBL1200675","canonicalSmiles":"CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"IWEQQRMGNVVKQW-OQKDUQJOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOREMIFENE CITRATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1655","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fareston"],"synonyms":["FC-1157A","NSC-613680","Toremifene citrate"],"crossReferences":{"DailyMed":["toremifene%20citrate"],"PubChem":["144205430","144212057","486747","49681796","50085986"]},"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003931","MONDO_0004658","MONDO_0007254","EFO_0003882","EFO_0000305"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 3 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200695","canonicalSmiles":"CC(N)C(O)c1ccccc1.Cl","inchiKey":"DYWNLSQWJMTVGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLPROPANOLAMINE HYDROCHLORIDE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL61006","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Neurotoxicity"],"year":2002},"tradeNames":["Dexatrim","Dimotapp","Dimotapp l.a.","Eskornade","Procol","Propagest","Sine-off","Triogesic","Triominic"],"synonyms":["NSC-23798","Norephedrine hydrochloride","Phenylpropanolamine chloride","Phenylpropanolamine hcl","Phenylpropanolamine hydrochloride","Propadrine hydrochloride"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000120907"],"count":2},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958. It was withdrawn in United States  in 2002 due to Neurotoxicity."}
{"id":"CHEMBL1200701","canonicalSmiles":"Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]","inchiKey":"SIGZQNJITOWQEF-VICXVTCVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DICLOXACILLIN SODIUM","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL893","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dicloxacillin sodium","Dycill","Dynapen","Pathocil"],"synonyms":["BRL-1702","Dicloxacillin sodium","Dicloxacillin sodium hydrate","Dicloxacillin sodium monohydrate","Dicloxacillin sodium salt monohydrate","Dicloxacillinum natricum","NSC-756726","P-1011","Sodium dicloxacillin","Sodium dicloxacillin monohydrate"],"crossReferences":{"DailyMed":["dicloxacillin%20sodium"],"PubChem":["144207044","170465296","56463521"],"chEBI":["52019"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and is indicated for infection and has 1 investigational indication."}
{"id":"CHEMBL1200833","canonicalSmiles":"CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1.Cl","inchiKey":"VKFAUCPBMAGVRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPIVEFRIN HYDROCHLORIDE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201262","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akpro","Dipivefrin hydrochloride","Propine"],"synonyms":["Dipivefrin hcl","Dipivefrin hydrochloride","Dipivefrine hydrochloride"],"crossReferences":{"PubChem":["144204226","56463529"],"chEBI":["4647"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980."}
{"id":"CHEMBL1201151","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C","inchiKey":"IMSSROKUHAOUJS-MJCUULBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESTRANOL","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["33355","EE-3ME","EE3 ME","EE3-ME","EE3ME","EEI3ME","Mestranol","NSC-84032"],"crossReferences":{"PubChem":["144204751","144212154","170465357","29215140","56422167","8139980"],"Wikipedia":["Mestranol"],"drugbank":["DB01357"],"chEBI":["6784"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL1201304","canonicalSmiles":"CC1(C)C(/C=C/C=C/C=C/C=C2\\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21","inchiKey":"BDBMLMBYCXNVMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOCYANINE GREEN","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ic-green"],"synonyms":["Indocyanine Green","Indocyanine green"],"crossReferences":{"DailyMed":["indocyanine%20green"]},"childChemblIds":["CHEMBL1646"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 19 investigational indications."}
{"id":"CHEMBL1201323","canonicalSmiles":"NCCc1cc[nH]n1","inchiKey":"JXDFEQONERDKSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAZOLE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betazole"],"crossReferences":{"PubChem":["11112911"],"Wikipedia":["Betazole"],"drugbank":["DB00272"],"chEBI":["59170"]},"childChemblIds":["CHEMBL1200949","CHEMBL4303510"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201373","canonicalSmiles":"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21","inchiKey":"QLJODMDSTUBWDW-BXMDZJJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEVINOLINIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mevinolinic acid"],"crossReferences":{"drugbank":["DB03785"],"chEBI":["82985"]},"childChemblIds":["CHEMBL487721","CHEMBL175236"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201635","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE BEEF/PORK","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nph iletin i (beef-pork)"],"synonyms":["Insulin susp isophane beef/pork"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1966."}
{"id":"CHEMBL1201697","drugType":"Protein","blackBoxWarning":false,"name":"LH (MENOTROPINS)","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Human lh","Lh (menotropins)"],"linkedTargets":{"rows":["ENSG00000138039"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0008560","EFO_0000660"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1975 and has 1 investigational indication."}
{"id":"CHEMBL1213135","canonicalSmiles":"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)/C=C\\C(=O)O","inchiKey":"YREISLCRUMOYAY-IIPCNOPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGONOVINE MALEATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL119443","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ergotrate","Ergotrate maleate"],"synonyms":["Cornocentin","Ergometrine hydrogen maleate","Ergometrine maleate","Ergometrini hydrogenomaleas","Ergonovine maleate","Ermetrine","NSC-93752"],"crossReferences":{"chEBI":["31554"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1213368","canonicalSmiles":"CCc1c(C)[nH]n(-c2nnn[nH]2)c1=O","inchiKey":"WAVWUEFMWJZZFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213368","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07824"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230044","canonicalSmiles":"N[C@H]1CN(C(=O)c2cnc3ccccc3n2)C[C@H]1C(=O)N1CCCC1","inchiKey":"XDSKICAQKGYYJF-OLZOCXBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230044","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07015"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230609","canonicalSmiles":"COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1","inchiKey":"CXQHYVUVSFXTMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORETINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EXEL-2880","Foretinib","GSK-089","GSK-1363089","GSK-1363089G","GSK089","GSK1363089G","Gsk-1363089","Gsk1363089","XL-880","XL880"],"crossReferences":{"PubChem":["137275948"],"drugbank":["DB12307"]},"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000120156","ENSG00000105976","ENSG00000157404","ENSG00000113721","ENSG00000122025"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000681","MONDO_0008903","EFO_0000182","MONDO_0007254","EFO_0005950","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1235413","canonicalSmiles":"Cc1ccc(CCC(=O)O)cc1","inchiKey":"LDYGRLNSOKABMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235413","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03400"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256175","canonicalSmiles":"CC(=O)O.CNC(=N)NCCC[C@H](N)C(=O)O","inchiKey":"IKPNWIGTWUZCKM-JEDNCBNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILARGININE ACETATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL256147","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANO-1020","L-nmma acetate","Ng-methylarginine acetate","Ng-monomethyl-l-arginine acetate","Targinine acetate","Tilarginine acetate"],"crossReferences":{"PubChem":["144204797","144207069","144207127","56463670"]},"linkedTargets":{"rows":["ENSG00000164867","ENSG00000089250","ENSG00000007171"],"count":3},"linkedDiseases":{"rows":["HP_0031273"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1308","canonicalSmiles":"Cc1cn[nH]c1","inchiKey":"RIKMMFOAQPJVMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOMEPIZOLE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antizol","Fomepizole"],"synonyms":["4-MP","4-methylpyrazole","Fomepizole","NSC-760365"],"crossReferences":{"DailyMed":["fomepizole"],"PubChem":["11111426","50111124","90341211"],"Wikipedia":["Fomepizole"],"drugbank":["DB01213"],"chEBI":["5141"]},"childChemblIds":["CHEMBL1256285"],"linkedTargets":{"rows":["ENSG00000187758","ENSG00000248144","ENSG00000196616"],"count":3},"linkedDiseases":{"rows":["EFO_0001365"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and has 1 investigational indication."}
{"id":"CHEMBL13209","canonicalSmiles":"O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1","inchiKey":"KJONHKAYOJNZEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITRAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mogadon","Nitrados","Remnos","Somnite","Unisomnia"],"synonyms":["Benzalin","N05CD02","NSC-58775","Nitrazepam","Nitrazepamum","RO 4-5360","RO 5-3059","RO-4-5360","RO-45360","RO-5-3059","RO-53059"],"crossReferences":{"PubChem":["144205154","170465667","29215277","50086824"],"Wikipedia":["Nitrazepam"],"drugbank":["DB01595"],"chEBI":["7581"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL132722","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"CAWZRIXWFRFUQB-IOSLPCCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha,beta-MeATP"],"crossReferences":{"PubChem":["26756671","90341608"],"drugbank":["DB02596"],"chEBI":["35056"]},"childChemblIds":["CHEMBL1257023"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1334860","canonicalSmiles":"CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1","inchiKey":"BDYYDXJSHYEDGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILOXANIDE FUROATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Entamizole","Furamide"],"synonyms":["Dichlofurazol","Diloxanide furoate","Diloxanidi furoas","Furentomin","Histomibal","NSC-759146"],"crossReferences":{"PubChem":["11112544","144207041","170466783","56422440","855852"],"Wikipedia":["Diloxanide_furoate"],"drugbank":["DB14638"],"chEBI":["4601"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL133809","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1N","inchiKey":"CQKMBZHLOYVGHW-QYYRPYCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL133809","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL146428","canonicalSmiles":"N=C1NC(=O)N2CC12","inchiKey":"BIXBBIPTYBJTRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMEXON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Amplimexon"],"synonyms":["Imexon","NSC-313425"],"crossReferences":{"PubChem":["144206332","455679","50125901","92763386"],"drugbank":["DB05003"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1542","canonicalSmiles":"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12","inchiKey":"LMEKQMALGUDUQG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AZATHIOPRINE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azamune","Azapress","Azasan","Azathioprine","Berkaprine","Immunoprin 50","Imuran","Kentaprine","Oprisine 50"],"synonyms":["Azathioprine","Azathioprinum","BW-57-322","NSC-39084"],"crossReferences":{"DailyMed":["azathioprine","azathioprine%20sodium"],"PubChem":["104171105","11110740","11110741","124879189","144203625","144213985","170464989","17390031","174006316","26670994","26747870","26747871","26747872","26752814","50105466","50105467","50105468","85230906","90340846"],"TG-GATEs":["46"],"Wikipedia":["Azathioprine"],"drugbank":["DB00993"],"chEBI":["2948"]},"childChemblIds":["CHEMBL1200400","CHEMBL3785814","CHEMBL3785780"],"linkedTargets":{"rows":["ENSG00000128059"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","Orphanet_232","EFO_0000318","EFO_0004274","EFO_0000768","EFO_0000540","EFO_0006803","EFO_0005676","EFO_0007160","EFO_0005531","EFO_0002690","MONDO_0002898","EFO_0000182","EFO_0003884","EFO_0004244","EFO_0007208","EFO_0004826","EFO_0004991","EFO_1000749","EFO_0004719","EFO_0000198","EFO_0000685","EFO_0005761","EFO_1001857","EFO_0009012","Orphanet_79213","EFO_0000545","HP_0000964","EFO_0000222","EFO_0004194","EFO_0003818","EFO_0000384","HP_0001873","EFO_1000784","EFO_0009448","EFO_0004599","EFO_0007187","EFO_0005297","EFO_0004256","EFO_0003767"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and is indicated for rheumatoid arthritis and immune system disease and has 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL156025","canonicalSmiles":"CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O","inchiKey":"PSWFFKRAVBDQEG-YGQNSOCVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"THYMOPENTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arg-lys-asp-val-tyr","Hg-thymopentin","Immunox","NSC-760116","ORF 15244","ORF-15244","Oristar thymopentin","Pentapeptide-1","Sh-pentapeptide-1","Sintomodulina","TP-5","Thymopentin","Thymopoetin 32-36-pentapeptide","Thymopoietin 32-36","Thymopoietin pentapeptide","Timunox"],"crossReferences":{"PubChem":["144205973"],"Wikipedia":["Thymopentin"]},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1697854","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(C)=N/NC(=O)c1ccccc1)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1","inchiKey":"FBTUMDXHSRTGRV-ALTNURHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZORUBICIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RP 22,050","RP-22050","Zorubicin"],"childChemblIds":["CHEMBL2105778"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1728","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21.Cl","inchiKey":"KXEBLAPZMOQCKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOMEFLOXACIN HYDROCHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL561","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxaquin"],"synonyms":["Lomefloxacin (as hydrochloride)","Lomefloxacin hcl","Lomefloxacin hydrochloride","Lomefloxacin monohydrochloride","NSC-758168","NY-198","SC-47111"],"crossReferences":{"PubChem":["144204267","144206705","170465262","26747546","50106492"],"chEBI":["6518"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and has 1 investigational indication."}
{"id":"CHEMBL1743042","drugType":"Antibody","blackBoxWarning":false,"name":"MOTAVIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Numax"],"synonyms":["MEDI-524","Motavizumab"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743052","drugType":"Antibody","blackBoxWarning":false,"name":"OPORTUZUMAB MONATOX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Proxinium","Proxinium, Vicinium","Vicineum","Vicinium"],"synonyms":["4D5MOCB-ETA","Oportuzumab monatox","VB4-845","XD60E5X7FI"],"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["EFO_0000294","MONDO_0001187"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743080","drugType":"Antibody","blackBoxWarning":false,"name":"TIGATUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-dr5 moab","Anti-trail-r2 moab","CS-1008","TRA-8","Tigatuzumab"],"linkedTargets":{"rows":["ENSG00000120889"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_1001480","MONDO_0008170","EFO_0000182","EFO_0004142","EFO_0000574","EFO_0003060","EFO_0000311"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL175247","canonicalSmiles":"CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O","inchiKey":"AHLBNYSZXLDEJQ-FWEHEUNISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORLISTAT","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alli","Beacita","Xenical"],"synonyms":["Lipstatin","NSC-758881","Orlipastat","Orlistat","RO 18-0647/002","RO-180647-002","RO-180647002","Tetrahydrolipstatin"],"crossReferences":{"DailyMed":["orlistat"],"PubChem":["26719846","29217614","49681644","93576635"],"Wikipedia":["Orlistat"],"drugbank":["DB01083"]},"linkedTargets":{"rows":["ENSG00000175535","ENSG00000182333"],"count":2},"linkedDiseases":{"rows":["HP_0012115","EFO_0000195","HP_0001397","EFO_0000545","Orphanet_411","EFO_0001073","MONDO_0005148","EFO_0000660"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for obesity and has 4 investigational indications."}
{"id":"CHEMBL1757","canonicalSmiles":"C[C@@H]1O[C@@H]1P(=O)(O)O","inchiKey":"YMDXZJFXQJVXBF-STHAYSLISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFOMYCIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fosfocina"],"synonyms":["Calcium fosfomycin","Fosfomycin","Fosfomycin calcium","Fosfomycin calcium hydrate","Fosfomycin sodium","J01XX01","Monurol","NSC-758170","ZTI-01","Zti-01"],"crossReferences":{"DailyMed":["fosfomycin%20tromethamine"],"Wikipedia":["Fosfomycin"],"drugbank":["DB00828"],"chEBI":["28915"]},"childChemblIds":["CHEMBL2322189","CHEMBL3188549","CHEMBL1200331","CHEMBL4576729","CHEMBL1256140"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for urinary tract infection and bacterial disease and has 13 investigational indications."}
{"id":"CHEMBL1769","canonicalSmiles":"CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC.Cl","inchiKey":"GITPCGSPKUQZTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPOXYCAINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1195","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blockain hydrochloride","Ravocaine hydrochloride"],"synonyms":["NSC-760044","Propoxycaine HCl","Propoxycaine hcl","Propoxycaine hydrochloride"],"crossReferences":{"PubChem":["144204013","56463554"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1773","canonicalSmiles":"CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F","inchiKey":"GAGWJHPBXLXJQN-UORFTKCHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CAPECITABINE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capecitabine","Xeloda"],"synonyms":["Capecitabine","Capecitabine accord","Capecitabine medac","Capecitabine sun","Capecitabine teva","Capecitibine","Capecytabine","Capiibine","Captabin","Ecansya","NSC-759853","RO 09-1978/000","RO-09-1978000","RO-091978000","Xeloda"],"crossReferences":{"DailyMed":["capecitabine"],"PubChem":["144205751","170464779"],"Wikipedia":["Capecitabine"],"drugbank":["DB01101"],"chEBI":["31348"]},"linkedTargets":{"rows":["ENSG00000176890"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0003891","EFO_0005543","EFO_0000365","EFO_0001075","EFO_0000756","EFO_0000681","EFO_1000657","EFO_0005952","EFO_0000228","EFO_1000984","EFO_1001951","EFO_0000178","EFO_0000588","MONDO_0002974","EFO_0000389","MONDO_0008903","EFO_0000182","MONDO_0005411","EFO_0008528","EFO_1000251","EFO_0004288","EFO_1000045","EFO_1001949","EFO_0002618","EFO_0005922","MONDO_0002108","MONDO_0021321","MONDO_0008170","EFO_0005842","EFO_0005221","MONDO_0008315","MONDO_0001879","EFO_0009708","MONDO_0002691","MONDO_0002165","MONDO_0044787","EFO_0005537","EFO_0009259","EFO_0004284","EFO_0008490","MONDO_0021640","EFO_0002938","MONDO_0100342","EFO_1001901","MONDO_0015686","EFO_0007416","MONDO_0007254","EFO_0004252","MONDO_0021063","MONDO_0002087","EFO_0000305","MONDO_0044937","MONDO_0001056","EFO_1001480","EFO_1000044","EFO_1000218","MONDO_0002158","EFO_0003860","EFO_0006352","MONDO_0002898","MONDO_0001657","EFO_0000326","EFO_0000707","EFO_0005588","EFO_1001893","EFO_0002617","EFO_1000158","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0005774","EFO_0002916","EFO_0000503","EFO_0000478","MONDO_0007576","EFO_0000313","EFO_0003060","EFO_0000311","EFO_1001961","EFO_1001471","EFO_0003865","MONDO_0002120","EFO_0006861","EFO_0002517","EFO_0004142","MONDO_0002367","MONDO_0003219","EFO_1000081","MONDO_0024880","EFO_0000181","EFO_0000519","MONDO_0044926"],"count":94},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 7 approved and 74 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL186314","canonicalSmiles":"O=C([O-])[O-].[Na+].[Na+]","inchiKey":"CDBYLPFSWZWCQE-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM CARBONATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Anhydrous sodium carbonate","Carbonic acid sodium salt (1:2)","Carbonic acid, disodium salt","Dried sodium carbonate","E-500(I)","E500","INS NO.500(I)","INS-500(I)","NSC-156204","Natrum carbonicum","Soda ash","Soda-ash","Sodium carbonate","Sodium carbonate (anhydrous)","Sodium carbonate anhydrous","Sodium carbonate, anhydrous","Sodium salt of carbonic acid","Solvay soda"],"crossReferences":{"DrugCentral":["5132"],"Wikipedia":["Sodium_carbonate"],"drugbank":["DB09460"],"chEBI":["29377"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1863514","drugType":"Enzyme","blackBoxWarning":false,"name":"ASPARAGINASE ERWINIA CHRYSANTHEMI","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erwinase[r] erwinaze[tm]","Erwinaze","Rylaze"],"synonyms":["Asparaginase erwinia chrysanthemi","Asparaginase erwinia chrysanthemi (recombinant)","Asparaginase erwinia chrysanthemi (recombinant)-rywn","JZP-458","crisantaspase (INN)"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for acute lymphoblastic leukemia and lymphoblastic lymphoma and has 3 investigational indications."}
{"id":"CHEMBL1961796","canonicalSmiles":"CCOC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)C1","inchiKey":"MMJJNHOIVCGAAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR9009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14013"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096633","canonicalSmiles":"O=[Si]([O-])O[Si]([O-])([O-])O[Si](=O)[O-].[Mg+2].[Mg+2]","inchiKey":"GXGAKHNRMVGRPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM TRISILICATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2109882","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mag trisil co","Trimax"],"synonyms":["Magnesium silicates magnesium trisilicate","Magnesium trisilicate"],"crossReferences":{"drugbank":["DB09281"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL2103877","canonicalSmiles":"C=C1CCN([C@H](C)[C@](O)(Cn2cncn2)c2ccc(F)cc2F)CC1","inchiKey":"NFEZZTICAUWDHU-RDTXWAMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFINACONAZOLE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jublia"],"synonyms":["Clenafin","Efinaconazole","IDP-108","KP-103"],"crossReferences":{"DailyMed":["efinaconazole"],"drugbank":["DB09040"],"chEBI":["82718"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014 and is indicated for tinea."}
{"id":"CHEMBL2105680","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c([O-])c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C.[Na+]","inchiKey":"YVOFSHPIJOYKSH-NLYBMVFSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFAMYCIN SODIUM","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL437765","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aemcolo"],"synonyms":["CB-01-11","CB-0111","RIFAMYCIN SV","Rifamastene","Rifamycin","Rifamycin sodium","Rifamycin sv sodium salt"],"crossReferences":{"DailyMed":["rifamycin%20sodium"],"PubChem":["144205617","144210004"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for diarrhea."}
{"id":"CHEMBL2105862","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](Cc3ccc(O)cc3)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N2.Cl","inchiKey":"LIODALMQEWEPTB-OWIKXPBHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ISEGANAN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110753","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IB-367-03","Iseganan hydrochloride","Iseganan hydrochloride anhydrous","Iseganan hydrochloride hydrate"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105894","canonicalSmiles":"O=C([O-])[O-].[K+].[K+]","inchiKey":"BWHMMNNQKKPAPP-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASH, SULFURATED","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107315","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C.Cl","inchiKey":"SJKBXKKZBKCHET-UQIIZPHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELOTECAN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2111084","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Belotecan hcl","Belotecan hydrochloride","CKD-602"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107331","canonicalSmiles":"CC[C@H]1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21","inchiKey":"RUJBDQSFYCKFAA-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTOFISOPAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextofisopam","R-TOFISOPAM"],"crossReferences":{"drugbank":["DB06582"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107342","canonicalSmiles":"CCCN1C[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@H]1C","inchiKey":"VWAMTBXLZPEDQO-UZSBJOJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GAMITHROMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gamithromycin","ML-1,709,460","ML-1709460","ML-460","Zactran"],"crossReferences":{"drugbank":["DB11416"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108429","drugType":"Antibody","blackBoxWarning":false,"name":"MEPOLIZUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bosatria","Nucala"],"synonyms":["Mepolizumab","SB-240563"],"crossReferences":{"DailyMed":["mepolizumab"],"DrugCentral":["5061"]},"linkedTargets":{"rows":["ENSG00000113525"],"count":1},"linkedDiseases":{"rows":["EFO_0006803","EFO_0004232","HP_0006536","EFO_0005531","EFO_1000391","EFO_0005297","EFO_1000024","MONDO_0004979","EFO_0007208","EFO_0000341","EFO_0000274","EFO_1001467","HP_0001880"],"count":13},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 5 approved and 7 investigational indications."}
{"id":"CHEMBL2108738","drugType":"Antibody","blackBoxWarning":false,"name":"NIVOLUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Opdivo"],"synonyms":["BMS-936558","BMS-986298","MDX-1106","Nivolumab","ONO-4538"],"crossReferences":{"DailyMed":["nivolumab"],"DrugCentral":["4923"]},"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_1000256","EFO_0003891","EFO_0000637","EFO_0000365","EFO_0000558","EFO_0000756","EFO_0000681","EFO_0005952","EFO_0007304","MONDO_0044704","EFO_1000984","EFO_0000632","EFO_1001951","MONDO_0015760","EFO_0000588","EFO_0000564","EFO_0000096","EFO_0000339","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0008528","EFO_0000514","Orphanet_2495","MONDO_0002038","EFO_1001949","EFO_0000198","EFO_0002618","EFO_1001931","EFO_0005922","MONDO_0019465","EFO_0001642","EFO_0000180","EFO_1001973","EFO_1001512","EFO_1001968","EFO_0004197","MONDO_0004986","MONDO_0008315","EFO_0005221","EFO_1000026","MONDO_0002691","EFO_0003032","MONDO_0000544","MONDO_0002547","EFO_0000335","EFO_0008524","EFO_0004284","EFO_0000574","EFO_0001378","EFO_1000796","MONDO_0002928","EFO_1001972","MONDO_0021117","MONDO_0045069","EFO_1001465","MONDO_0007254","EFO_0004252","MONDO_0003541","MONDO_0020654","MONDO_0001056","MONDO_0002158","Orphanet_377","EFO_0003968","EFO_1001974","MONDO_0002898","EFO_0000196","EFO_0000326","EFO_0000183","EFO_0004193","EFO_0000707","EFO_0000616","EFO_0006859","EFO_1000603","EFO_0002916","MONDO_0024503","EFO_1000314","Orphanet_44890","EFO_0000403","EFO_0000222","MONDO_0000870","MONDO_0007576","EFO_0000304","EFO_1001471","MONDO_0002120","MONDO_0021148","EFO_0002517","EFO_0000702","EFO_0000199","MONDO_0002367","MONDO_0018906","MONDO_0024880","EFO_1001927","EFO_0000519","MONDO_0003060","HP_0002745","EFO_0005543","EFO_0001075","EFO_0000571","EFO_1000575","MONDO_0045056","EFO_1000657","EFO_0000228","EFO_0000565","Orphanet_178","MONDO_0017582","EFO_0009709","EFO_0000389","EFO_0000182","MONDO_0020634","EFO_0007541","EFO_1000785","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_0003017","EFO_1000157","MONDO_0004669","MONDO_0017596","MONDO_0044881","EFO_1000344","EFO_0004239","HP_0100806","EFO_0001061","MONDO_0100096","EFO_0005537","EFO_1001051","EFO_0006544","EFO_1000613","EFO_0000563","MONDO_0009348","MONDO_0100342","MONDO_0015686","MONDO_0044887","EFO_0000708","MONDO_0021063","MONDO_0002087","MONDO_0024879","EFO_1001469","EFO_0000305","MONDO_0020657","EFO_0003085","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_0007466","EFO_0000770","MONDO_0001657","EFO_0000673","MONDO_0020743","EFO_0002617","EFO_1000616","EFO_0000503","EFO_0000478","EFO_1000508","EFO_0000313","EFO_0004243","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0000640","EFO_0003863","EFO_0000095","EFO_0002892","EFO_0004142","MONDO_0003219","EFO_1000081","EFO_0003050","EFO_0000691","MONDO_0021637","EFO_0000181","EFO_0003833","EFO_1001950"],"count":175},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 12 approved and 126 investigational indications."}
{"id":"CHEMBL2109356","drugType":"Antibody","blackBoxWarning":false,"name":"BIIB-022","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-022","Biib 022","Biib-022"],"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000182","EFO_0003060"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109438","drugType":"Antibody","blackBoxWarning":false,"name":"MBL-HCV-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MBL-HCV-1","Mbl-hcv-1"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2146121","canonicalSmiles":"[CaH2]","inchiKey":"FAQLAUHZSGTTLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Calcium"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 42 investigational indications."}
{"id":"CHEMBL215645","canonicalSmiles":"CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"GWHQHAUAXRMMOT-MERQFXBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVASTIGMINE TARTRATE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL636","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exelon","Rivastigmine tartrate"],"synonyms":["ENA 713","Rivastigmine Tartrate","Rivastigmine actavis","Rivastigmine bitartrate","Rivastigmine hydrogen tartrate","Rivastigmine hydrogentartrate","Rivastigmine tartrate","Sdz-ena 713"],"crossReferences":{"DailyMed":["rivastigmine%20tartrate"]},"linkedTargets":{"rows":["ENSG00000087085","ENSG00000114200"],"count":2},"linkedDiseases":{"rows":["HP_0000726","MONDO_0005180","EFO_0005252"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for dementia and parkinson disease and has 1 investigational indication."}
{"id":"CHEMBL227123","canonicalSmiles":"NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12","inchiKey":"JLSKPBDKNIXMBS-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Trp-NH2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trp-NH2"],"crossReferences":{"drugbank":["DB04537"],"chEBI":["16533"]},"childChemblIds":["CHEMBL1222006"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL251940","canonicalSmiles":"N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2","inchiKey":"LUALIOATIOESLM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERICIAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neulactil"],"synonyms":["NSC-758641","Periciazine","Pericyazine","Propericiazine","RP 8909","RP-8909","SKF 20716","SKF-20716"],"crossReferences":{"PubChem":["144204970","26748871"],"drugbank":["DB01608"],"chEBI":["31981"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for psychosis."}
{"id":"CHEMBL266125","canonicalSmiles":"Cc1ccc2cc(C(=O)NC3(C(=O)N[C@H](Cc4ccccc4)C(=O)NCC4CCN(CC5CCOCC5)CC4)CCCC3)sc2c1","inchiKey":"YQYSVMKCMIUCHY-WJOKGBTCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBODUTANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibodutant","Men15596"],"crossReferences":{"drugbank":["DB12042"]},"linkedTargets":{"rows":["ENSG00000075073"],"count":1},"linkedDiseases":{"rows":["EFO_0000555"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL270875","canonicalSmiles":"NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21","inchiKey":"APYXQTXFRIDSGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL270875","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07457"],"chEBI":["41059"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL274047","canonicalSmiles":"O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1","inchiKey":"CEIJFEGBUDEYSX-FZDBZEDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANDOSPIRONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tandospirone"],"crossReferences":{"PubChem":["144206869"],"Wikipedia":["Tandospirone"],"drugbank":["DB12833"]},"childChemblIds":["CHEMBL1628275","CHEMBL2103888"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279956","canonicalSmiles":"N[C@@H](Cn1oc(=O)[nH]c1=O)C(=O)O","inchiKey":"ASNFTDCKZKHJSW-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUISQUALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quisqualate","quisqualic acid"],"crossReferences":{"PubChem":["11113399","26751639","47193871","50104331","90341112"],"Wikipedia":["Quisqualic_acid"],"drugbank":["DB02999"],"chEBI":["8734"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282724","canonicalSmiles":"Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2","inchiKey":"PHWXUGHIIBDVKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITAXENTAN","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Hepatotoxicity"],"year":2010},"tradeNames":[],"synonyms":["IPI-1040","Sitaxentan","Sitaxsentan","TBC-11251"],"crossReferences":{"PubChem":["170465720"],"Wikipedia":["Sitaxentan"],"drugbank":["DB06268"]},"childChemblIds":["CHEMBL2105740"],"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0001361","HP_0000093","EFO_0003884","MONDO_0004979","EFO_0000537","EFO_1000899"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for hypertension and has 6 investigational indications. It was withdrawn in European Union  in 2010 due to Hepatotoxicity."}
{"id":"CHEMBL292821","canonicalSmiles":"COc1cc(CCN)c(OC)cc1Br","inchiKey":"YMHOBZXQZVXHBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL292821","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["2C-B"],"drugbank":["DB01537"],"chEBI":["189669"]},"childChemblIds":["CHEMBL2362607"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL295433","canonicalSmiles":"C[C@H]1CN(c2c(F)c(F)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1","inchiKey":"QIPQASLPWJVQMH-DTORHVGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORBIFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Orbax"],"synonyms":["NSC-758614","Orbifloxacin"],"crossReferences":{"PubChem":["144205420","170465644","29216200","29216201","49647788"],"Wikipedia":["Orbifloxacin"],"drugbank":["DB11443"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL297302","canonicalSmiles":"O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1","inchiKey":"FEBOTPHFXYHVPL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENPERIDOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anquil","Benquil"],"synonyms":["Benperidol","MCN-JR-4584","NSC-170982","R-4584"],"crossReferences":{"PubChem":["11112508","144204068","170466409","56463215"],"Wikipedia":["Benperidol"],"drugbank":["DB12867"]},"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230","EFO_0005411"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL298019","canonicalSmiles":"CCOC(=O)c1ccc(OCCC2CCN(c3ccc(C)nn3)CC2)cc1","inchiKey":"KCHIOGFOPPOUJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRODAVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pirodavir","R 77975","R-77975"],"crossReferences":{"drugbank":["DB08012"]},"childChemblIds":["CHEMBL4796326"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL299400","canonicalSmiles":"O=C(O)C(O)C(O)C(=O)O.Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3","inchiKey":"GMTYREVWZXJPLF-SXWPHCFWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUTORPHANOL TARTRATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL33986","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Butorphanol tartrate","Butorphanol tartrate preservative free","Stadol","Stadol ns","Stadol preservative free","Torbugesic","Torbutrol"],"synonyms":["Butorphanol tartrate","Butorphanol tartrate civ","Dolorex","LEVO-BC-2627 TARTRATE","Torbugesic","Torbutrol"],"crossReferences":{"DailyMed":["butorphanol%20tartrate"]},"linkedTargets":{"rows":["ENSG00000082556","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0003890","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978 and is indicated for drug dependence. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3039556","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"APATORSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apatorsen","OGX-427"],"linkedTargets":{"rows":["ENSG00000106211"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0000708","EFO_0003060","MONDO_0008315","MONDO_0001187"],"count":6},"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL307177","canonicalSmiles":"O=C(Nc1ccc(Cl)c(Cl)c1)NS(=O)(=O)c1ccc2c(c1)CCO2","inchiKey":"VAMFSFIPDOODFH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-295501","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ILX-295501","Ilx-295501","LY-295501","LY295501","Ly-295501"],"crossReferences":{"drugbank":["DB12574"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3301580","drugType":"Antibody","blackBoxWarning":false,"name":"FLETIKUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-IL-20","Fletikumab","NNC-0109-0012","NNC01 09-0012","NNC0109-0012"],"linkedTargets":{"rows":["ENSG00000162891"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0000685","EFO_0000676"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3306853","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@@H](c3ccccc3)S(=O)(=O)O)C(=O)N2[C@H]1C(=O)O","inchiKey":"JETQIUPBHQNHNZ-NJBDSQKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3306853","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13693"]},"childChemblIds":["CHEMBL4303686","CHEMBL3185827"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545049","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY-1125976","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1125976","Bay-1125976"],"linkedTargets":{"rows":["ENSG00000105221","ENSG00000142208"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3623290","canonicalSmiles":"COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C","inchiKey":"MXDSJQHFFDGFDK-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-3759","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD3759","Azd 3759","Azd-3759","Azd3759","Zorifertinib"],"crossReferences":{"drugbank":["DB14795"]},"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL368591","canonicalSmiles":"CCC(O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"QIRAYNIFEOXSPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMEPHEPTANOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acscn-9618","Amidol","Bimethadol","Dimepheptanol","IDS-ND-012","Methadol","NIH 2933","NIH-2933","Pangerin","Racemethadol"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL379760","canonicalSmiles":"COc1ccc(N(C(=O)Nc2ccccc2Cl)c2ccnc(N[C@@H](C)C(C)(C)O)n2)cc1","inchiKey":"ZWYFTKPEHRQCCW-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL379760","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08095"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833348","drugType":"Small molecule","blackBoxWarning":false,"name":"BISMUTH SUBNITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mammol"],"synonyms":["Bismuth hydroxide nitrate oxide","Bismuth nitrate, basic","Bismuth subnitrate","Bismuth subnitrate, heavy","Bismuthum subnitricum","C.i. 77169","C.i. pigment white 17"],"crossReferences":{"DrugCentral":["4841"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL383541","canonicalSmiles":"N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12","inchiKey":"SGHXFHRRWFLILP-XJDXJNMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383541","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07107"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL383675","canonicalSmiles":"Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc2CC4)C=C3)c1","inchiKey":"KSXLETNRCMCRAQ-LWQDQPMZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMOPORFIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Foscan"],"synonyms":["EF-9","EF9","Mthpc","Temoporfin"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 7 investigational indications."}
{"id":"CHEMBL389621","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"JYGXADMDTFJGBT-VWUMJDOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetasol hc","Acticort","Aeroseb-hc","Ala-cort","Ala-scalp","Alkindi sprinkle","Alphaderm","Anflam","Anucort-Hc","Anugesic hc","Anusol hc","Anusol plus hc","Anusol soothing relief","Anusol-Hc","Balneol-hc","Beta-hc","Calmurid hc","Canesten hc","Cetacort","Cipro hc","Cobadex","Colocort","Corlan","Cort-dome","Cortef","Cortenem","Cortenema","Cortril","Daktacort","Daktacort hydrocort","Derma care hydrocort","Dermacort","Dermaspray demang","Dioderm","Dome-cort","Econacort","Efcortelan p","Eldecort","Epicort","Eurax-hc","Eurax-hydrocort","Evacort","Exe-cort","Flexicort","Germoloids hc","Glycort","Gregoderm","H-cort","Hc #1","Hc #4","Hc (hydrocortisone)","Hi-cor","Hydro-rx","Hydrocort in calamine oily","Hydrocort in cetomacrogol for a","Hydrocort in wte soft paraf","Hydrocortisone","Hydrocortisone in absorbase","Hydrocortone","Hydroderm","Hydroderm hc","Hytone","Jungle for","Locoid","Medicort","Mildison lipocream","Nogenic hc","Nutracort","Nybadex","Nystaform-hc","Otoseptil","Otosporin","Penecort","Perinal","Plenadren","Proctocort","Proctocream hc","Proctofoam hc","Proctosedyl","Quinocort","Sential hc","Stie-cort","Synacort","Terra-cortril nystatin","Texacort","Timocort","Timodine","Topisone","Tri-cicatrin","Uniroid","Uniroid hc","Xyloproct","Zenoxone"],"synonyms":["Cor-Oticin","Cortifoam","Cortisol","FLEXICORT","Hydrocortisone","Micort-HC","NSC-10483","Neo-Cortef","Ophthocort","Terra-Cortril","U-Cort"],"crossReferences":{"DailyMed":["hydrocortisone"],"PubChem":["144204434","144208013","170464635","26751519","26751520","29215010","56422453","75748","85148352","855803","90341326"],"Wikipedia":["Cortisol"],"drugbank":["DB00741"],"chEBI":["17650"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0007543","EFO_0000729","MONDO_0000873","EFO_1001104","EFO_0000275","EFO_0000756","EFO_0003768","HP_0004798","EFO_0000565","EFO_0004251","EFO_1001347","EFO_0009560","EFO_0000544","MONDO_0019460","EFO_0000330","MONDO_0015540","EFO_0009552","EFO_0007541","EFO_0000094","EFO_0000198","EFO_0000221","EFO_0003802","HP_0012076","EFO_0000220","HP_0000964","EFO_1001908","EFO_0000223","EFO_1001946","EFO_0009516","HP_0001742","EFO_0000384","MONDO_0008315","EFO_0003025","Orphanet_418","HP_0100806","EFO_0000546","MP_0001845","GO_0007568","EFO_0001422","EFO_0004192","MONDO_0100096","EFO_0003032","Orphanet_90794","HP_0003074","MONDO_0002406","EFO_0000574","MONDO_0004979","EFO_0007328","EFO_0001378","EFO_0000218","EFO_1000796","HP_0031273","EFO_0005251","EFO_0009491","EFO_0005687","EFO_0003812","EFO_0006834","EFO_1001494","EFO_0000278","EFO_1001945","EFO_0000274","EFO_0000209","MONDO_0003541","EFO_1000044","EFO_0009444","EFO_1001216","Orphanet_70589","EFO_0003860","EFO_0003144","EFO_0000673","MONDO_0020743","MONDO_0007079","EFO_0005752","EFO_1000158","MONDO_0015128","EFO_1001779","MONDO_0026045","EFO_0000403","EFO_0000222","MONDO_0000870","EFO_0001358","EFO_0010702","EFO_0010445","EFO_0001073","HP_0002315","EFO_0000311","EFO_0003106","EFO_0001072","MONDO_0021340","EFO_0002614","MONDO_0005147","EFO_0000764","EFO_1001818","EFO_0007359","EFO_1001947","EFO_0007141","EFO_0005611","EFO_0000612","MONDO_0005178","EFO_0009492","EFO_0003027","EFO_0003811"],"count":102},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 12 approved and 68 investigational indications."}
{"id":"CHEMBL3989958","canonicalSmiles":"N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1","inchiKey":"WIJZXSAJMHAVGX-DHLKQENFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IVOSIDENIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tibsovo"],"synonyms":["AG-120","Ivosidenib"],"crossReferences":{"DailyMed":["ivosidenib"],"drugbank":["DB14568"]},"linkedTargets":{"rows":["ENSG00000138413"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0002517","EFO_0001421","EFO_0000326","EFO_0000222","EFO_0002427","EFO_0005221","EFO_0000333","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL403328","canonicalSmiles":"Cc1cn([C@H]2C=C[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"XLPGURCDSRIXFL-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL403328","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04672"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL403673","canonicalSmiles":"COc1ccc(Nc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)n2)cc1Cl","inchiKey":"ZVWFECUPYCFYBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL403673","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07251"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL408194","canonicalSmiles":"COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\\c1[nH]c(C)cc1C","inchiKey":"RFTSSZJZXOSICM-GRSHGNNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OBATOCLAX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GX15-070","Obatoclax"],"crossReferences":{"drugbank":["DB12191"]},"childChemblIds":["CHEMBL2107358"],"linkedTargets":{"rows":["ENSG00000140379","ENSG00000171552","ENSG00000258643","ENSG00000171791","ENSG00000137875","ENSG00000143384","ENSG00000129473"],"count":7},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0044903","EFO_0001642","EFO_0000403","EFO_0000222","EFO_1001469","MONDO_0001023","EFO_0000095","MONDO_0008903","EFO_0000702","MONDO_0018906","EFO_0000183","EFO_0001378","EFO_0002617"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL4164059","canonicalSmiles":"Cl.Clc1ccc(CCCOCCCN2CCCCC2)cc1","inchiKey":"XLFKECRRMPOAQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PITOLISANT HYDROCHLORIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL462605","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Wakix"],"synonyms":["Ciproxidine","Pitolisant hydrochloride"],"crossReferences":{"DailyMed":["pitolisant%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0005246","MONDO_0016158"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for hypersomnia and narcolepsy-cataplexy syndrome."}
{"id":"CHEMBL425863","canonicalSmiles":"C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@@H]21","inchiKey":"PTQMMNYJKCSPET-OMHQDGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIBOLERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cheque drops","Dihydrolone","Matenon","Mibolerone","Mibolerone ciii","NSC-72260","U-10,997","U-10-997","U-10997"],"crossReferences":{"PubChem":["170466095"],"Wikipedia":["Mibolerone"],"drugbank":["DB11429"],"chEBI":["34849"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297396","canonicalSmiles":"Cl.N#Cc1ccc(Cn2cncc2CN2CCN(c3cccc(Cl)c3)C(=O)C2)cc1","inchiKey":"YNBSQYGTJLIPJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-778123","maximumClinicalTrialPhase":1,"parentId":"CHEMBL279433","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-778,123","L-778123"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297513","canonicalSmiles":"CC(C)[C@@H](C)[C@@]1(C)CC[C@]2(C)[C@H]3CC[C@H]4[C@@]5(C)COC[C@@]4(C[C@@H](n4ncnc4-c4ccncc4)[C@@H]5OC[C@](C)(N)C(C)(C)C)C3=CC[C@@]2(C)[C@@H]1C(=O)O","inchiKey":"BODYFEUFKHPRCK-ZCZMVWJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBREXAFUNGERP","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ibrexafungerp","MK 3118","MK-3118","MK-3118 FREE BASE","SCY-078","Scy-078"],"crossReferences":{"drugbank":["DB12471"]},"childChemblIds":["CHEMBL4298168"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for vulvovaginal candidiasis and has 10 investigational indications."}
{"id":"CHEMBL4297514","canonicalSmiles":"C[C@H]1N=C(N(C)C)N=C(N)N1","inchiKey":"GFICWFZTBXUVIG-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMEGLIMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD-387008","Imeglimin"],"crossReferences":{"drugbank":["DB12509"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297552","drugType":"Unknown","blackBoxWarning":false,"name":"AMV-564","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMV-564","AMV564","Amv-564","Amv564","CNTO 3953 TANDAB","CNTO-3953","T-652","T652","Vixtimotamab"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297596","canonicalSmiles":"Cn1c(=O)oc2cc(-n3cc(C(=O)O)c(=O)n([C@@H]4CCc5c4cccc5C(F)(F)F)c3=O)ccc21","inchiKey":"JDARDSVOVYVQST-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FULACIMSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1142524","BAY1142524","Bay1142524","Fulacimstat"],"crossReferences":{"drugbank":["DB15085"]},"linkedTargets":{"rows":["ENSG00000092009"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000401","EFO_0000612"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297696","drugType":"Unknown","blackBoxWarning":false,"name":"AR-105","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-105","Aerucin","Ar-105"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297735","drugType":"Unknown","blackBoxWarning":false,"name":"CURDLAN SULFATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Curdlan sulfate"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4303214","canonicalSmiles":"CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12","inchiKey":"BALLNEJQLSTPIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FRUQUINTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fruquintinib","HMPL-013","HMPL013","Hmpl-013"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","EFO_0002618","EFO_0000365","EFO_1000657","MONDO_0007254","EFO_1001968","EFO_0003060","EFO_1001951","MONDO_0001056","EFO_1001480","MONDO_0008903","EFO_0001421","EFO_0004142","EFO_0009878"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL435","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O","inchiKey":"JZUFKLXOESDKRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCHLOROTHIAZIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apo-hydro","Esidrex","Esidrix","Hydro-d","Hydrochlorothiazide","Hydrochlorothiazide intensol","Hydrodiuril","Hydrosaluric","Microzide","Oretic","Zide"],"synonyms":["Apresazide","Carozide","Chlorosulthiadil","Copalia-hct","Dafiro-hct","Dihydrochlorurite","Exforge-hct","Hctz","Hidrotiazida","Hydrochlorothiaizide","Hydrochlorothiazide","Hydrochlorothiazidum","Idrotiazide","Imprida-hct","Lotensin hct","Megadiuril","NSC-53477","Newtolide","Pantemon","Rasilez-hct","SU-5879","Servithiazid","Unipres","Vetidrex"],"crossReferences":{"DailyMed":["hydrochlorothiazide"],"PubChem":["103995","11111269","11111270","144208763","144210612","170465005","17389854","26746944","50103978","85231074","855646"],"Wikipedia":["Hydrochlorothiazide"],"drugbank":["DB00999"],"chEBI":["5778"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0003124","EFO_0000401","EFO_0004278","EFO_0009373","EFO_0001645","EFO_0000373","EFO_0000319","MONDO_0002462","EFO_0000537","EFO_0003913","EFO_0000195","EFO_0001422","EFO_0003914","HP_0002900","MONDO_0001134","Orphanet_79292","EFO_0003144","EFO_0004253","EFO_0003884","EFO_0004255","EFO_0000612","MONDO_0005148","EFO_0003918","EFO_0000668","EFO_0000400"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 11 approved and 12 investigational indications."}
{"id":"CHEMBL437508","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O","inchiKey":"OIMACDRJUANHTJ-XPWFQUROSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL437508","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01717"],"chEBI":["28898"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594467","drugType":"Unknown","blackBoxWarning":false,"name":"CC-90006","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-90006","Cc-90006","Cc-90006 pd-1 agonist"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL462313","canonicalSmiles":"CC(C)N[C@@H]1CCn2c(=O)[nH]c3cccc(c32)[C@H]1O","inchiKey":"ZSTCZWJCLIRCOJ-DGCLKSJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Zilpaterol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zilpaterol"],"crossReferences":{"drugbank":["DB11479"]},"childChemblIds":["CHEMBL513390"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650333","canonicalSmiles":"COc1ccc(-c2cncc(N[C@@H](C)c3cccc(NC(=O)c4cncc(C)c4)c3)n2)cc1OC","inchiKey":"JHJNPOSPVGRIAN-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERALUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GB-002","GB002","Gb002","PK-10571","Seralutinib"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650472","drugType":"Antibody","blackBoxWarning":false,"name":"PUCOTENLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HX-008","HX008","Hx008","Pucotenlimab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","MONDO_0002108","EFO_0000756","EFO_0000182","EFO_0003060","MONDO_0001187"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4650523","drugType":"Unknown","blackBoxWarning":false,"name":"UCB-6114","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ginisortamab","UCB-6114","UCB6114","Ucb-6114","Ucb6114"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650524","drugType":"Antibody","blackBoxWarning":false,"name":"SOTROVIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-4182136","GSK4182136","Sotrovimab","VIR-7831","VIR7831","Vir-7831"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650827","canonicalSmiles":"CCN(C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(CCN(C[C@H]3CC[C@H](NS(=O)(=O)CC)CC3)CC2)C1)C(C)C","inchiKey":"FRVSRBKUQZKTOW-YOCNBXQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SNDX-5613 FREE BASE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4650278"],"linkedTargets":{"rows":["ENSG00000133895","ENSG00000118058"],"count":2},"linkedDiseases":{"rows":["EFO_0000220","MONDO_0020743"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL465123","canonicalSmiles":"NCC[C@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1","inchiKey":"WIQRCHMSJFFONW-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEPROXETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(s)-norfluoxetine","Norfluoxetine, (s)-","Seproxetine"],"crossReferences":{"drugbank":["DB06731"]},"childChemblIds":["CHEMBL2107550"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539165","canonicalSmiles":"Oc1ccc(C(F)(F)F)cc1","inchiKey":"BAYGVMXZJBFEMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR-1C13","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR-1C13"],"crossReferences":{"drugbank":["DB03610"],"chEBI":["42578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL556578","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.Cl","inchiKey":"XCKKIKBIPZJUET-VYKNHSEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORPHINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL70","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Morph hcl"],"synonyms":["(-)-morphine hydrochloride","Epimore","Morphine Hydro Chloride","Morphine chlorhydrate","Morphine hcl","Morphine hydrochloride","Morphine hydrochloride hydrate","Morphine hydrochloride trihydrate","Morphini hydrochloridum","Morphinum muriaticum","Thebametten","Vendal"],"crossReferences":{"chEBI":["55340"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL577120","canonicalSmiles":"N#Cc1c[nH]c2nc(N)[nH]c(=O)c12","inchiKey":"FMKSMYDYKXQYRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL577120","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03074"],"chEBI":["45075"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL708","canonicalSmiles":"O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1","inchiKey":"MVWVFYHBGMAFLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZIPRASIDONE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-88059","Geodon","Zipradon","Ziprasidone"],"crossReferences":{"DailyMed":["ziprasidone%20hydrochloride","ziprasidone%20mesylate"],"PubChem":["144205747","144207074","170465342","26719835"],"Wikipedia":["Ziprasidone"],"drugbank":["DB00246"],"chEBI":["10119"]},"childChemblIds":["CHEMBL1712","CHEMBL1200997","CHEMBL3989833","CHEMBL1375743"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002009","HP_0012076","EFO_0004269","HP_0000726","EFO_0000677","EFO_0003758","EFO_0009963","EFO_0005407","EFO_0000319","EFO_1001917","HP_0000713","EFO_0004247","EFO_0000289","MONDO_0002050","EFO_0003890","EFO_0005306","EFO_0005611","EFO_0005230","EFO_0005411"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 8 approved and 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL776","canonicalSmiles":"CC(C)NCC(O)c1cc(O)cc(O)c1","inchiKey":"LMOINURANNBYCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METAPROTERENOL","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Metaproterenol","Orciprenaline"],"crossReferences":{"DailyMed":["metaproterenol%20sulfate"],"PubChem":["26748125","90340962"],"Wikipedia":["Orciprenaline"],"drugbank":["DB00816"],"chEBI":["6792"]},"childChemblIds":["CHEMBL1200812","CHEMBL1568057","CHEMBL2164775","CHEMBL1628446"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0003890","MONDO_0004979"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for asthma and airway obstruction and has 1 investigational indication."}
{"id":"CHEMBL81273","canonicalSmiles":"CC1(C)CCC(C)(C)c2cc([C@@H](O)c3ccc4cc(C(=O)O)ccc4c3)ccc21","inchiKey":"AYAJZQYENGWICE-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL81273","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03466"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL86882","canonicalSmiles":"CCNCC(O)c1cccc(O)c1","inchiKey":"SQVIAVUSQAWMKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETILEFRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Effortil","Effortil depot perlongetten"],"synonyms":["Apocretin","Cardanat","Circupon","Corcanfol","Dl-etilefrin","Effontil","Efortil","Ethylefrine","Etilefrin","Etilefrin hydrochloride","Etilefrine","Etilefrine hcl","Etilefrine hydrochloride","Kertasin","N-ethylnorphenylephrine","Phetanol","Pulsamin","S-40032","S-40032-7","Thomasin","Updormin"],"crossReferences":{"PubChem":["50085437"],"Wikipedia":["Etilefrine"],"drugbank":["DB08985"]},"childChemblIds":["CHEMBL3187408"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL93247","canonicalSmiles":"N/C(S)=N/CCC[C@H](N)C(=O)O","inchiKey":"BKGWACHYAMTLAF-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL93247","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756870","90341707"],"drugbank":["DB03953"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL93747","canonicalSmiles":"O=C1NC(=O)C(Cc2ccc3cc(OCc4ccccc4F)ccc3c2)S1","inchiKey":"PKWDZWYVIHVNKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NETOGLITAZONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MCC 555","Mcc-555","Netoglitazone","PGX-510","RWJ-241947"],"crossReferences":{"drugbank":["DB09199"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL95606","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"UHDGCWIWMRVCDJ-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYTIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytidine","MMV638723","NSC-20258"],"crossReferences":{"PubChem":["26754267","93576752"],"Wikipedia":["Cytidine"],"drugbank":["DB02097"],"chEBI":["17562"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
